HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran

International Journal of Infectious Diseases

Volumn 14, Issue 1, 2010, Pages

  Rahimi Movaghar, Afarin ^b   Razaghi, Emran M ^a   Sahimi Izadian, Elaheh ^a   Amin Esmaeili, Masoumeh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis B; Hepatitis C; HIV; Injecting drug users; Iran; Prevalence

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; VIRUS TRANSMISSION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; COMORBIDITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; IRAN; MALE; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; URBAN POPULATION;

EID: 74649084422     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.03.002     Document Type: Article

References (41)

1. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 372 (2008) 1733-1745
2. Rahimi-Movaghar A., Mohammad K., and Razzaghi E.M. Trend of drug abuse in Iran: a three decade analysis [in Persian]. Hakim Res J 5 (2002) 171-182
3. Sulkowski M.S. Viral hepatitis and HIV coinfection. J Hepatol 48 (2008) 353-367
4. Pallás J.R., Fariñas-Álvarez C., Prieto D., and Delgado-Rodríguez M. Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. Eur J Epidemiol 15 (1999) 699-704
5. Hernandez-Aguado I., Ramos-Rincon J.M., Avinio M.J., Gonzalez-Aracil J., Perez-Hoyos S., and de la Hera M.G. Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users. Eur J Epidemiol 17 (2001) 539-544
6. National AIDS Committee, Ministry of Health. Iran Country report on monitoring of the United Nations general assembly special session on HIV and AIDS, declaration of commitment [in Persian]. Tehran: Iranian Ministry of Health; 2008, p. 19-21.
7. Alavian S.M., Adibi P., and Zali M.A. Hepatitis C virus in Iran: epidemiology of an emerging infection. Arch Iranian Med 8 (2005) 84-90
8. Forouzanfar M.H., Mohammad K., Majdzadeh R., Malekzadeh R., Abolhasani F., Mohammadnejad M., et al. Effectiveness of adolescent immunization against hepatitis B on burden of the disease in Iran [in Persian]. Hakim Res J 9 (2006) 1-11
9. Razzaghi E.M., Rahimi-Movaghar A., Green T.C., and Khoshnood K. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J 3 (2006) 12
10. Bureau for Psychosocial Health, Iranian Ministry of Health. National report on drug abuse services, 2007. Tehran: Iranian Ministry of Health; 2008.
11. Hagan H., Thiede H., and Des Jarlais D.C. HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS 19 Suppl 3 (2005) S199-207
12. Zamani S., Kihara M., Gouya M.M., Vazirian M., Nassirimanesh B., Ono-Kihara M., et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran. Iran. J Acquir Immune Defic Syndr 42 (2006) 342-346
13. Khamisipour G.R., and Tahmasebi R. Prevalence of HIV, HBV, HCV and syphilis infection in high risk groups of Bushehr Province, 1999 [in Persian]. Iranian South Med J 3 (2000) 53-59
14. Mohtasham Amiri Z., Rezvani M., Jafari Shakib R., and Jafari Shakib A. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan Province. East Mediterr Health J 13 (2007) 250-256
15. Khodadadi-Zadeh A., Esmaeili Nadimi A., Hosseini S.H., and Shabani Shahrbabaki Z. The prevalence of HIV, HBV and HCV in narcotic addicted persons referred to the outpatient clinic of Rafsanjan University of Medical Sciences in 2003 [in Persian]. J Rafsanjan Univ Med Sci 5 (2006) 23-30
16. Mirahmadizadeh A.R., Kadivar M.R., Ghane Shirazi R., and Fararooei M. Prevalence of HIV infection among intravenous drug addicts in Shiraz [in Persian]. J Gorgan Univ Med Sci 3 (2001) 39-41
17. Mir-Nasseri M.M., Poustchi H., Nasseri-Moghadam S., Nouraie S.M., Tahaghoghi S., Afshar P., et al. HCV in intravenous drug users [in Persian]. Govaresh 2 (2005) 80-86
18. Mohammad-Alizadeh A.H., Alavian A.M., Jafari K., and Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan - Iran. World J Gastroenterol 11 (2005) 4058-4089
19. Rowhani Rahbar A., Rooholamini S., and Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. Int J Drug Policy 15 (2004) 151-155
20. Salehi M., Sanei Moghaddam E., and Ansari Moghaddam A.R. HBsAg and hepatitis C infection prevalence in prisoners of Sistan and Balouchestan Province [in Persian]. Tabibe Shargh 4 (2001) 203-206
21. Zali M.R., Aghazadeh R., Nowroozi A., and Amir-Rasouly H. Anti-HCV antibody among Iranian IV drug users: is it a serious problem?. Arch Iranian Med 4 (2001) 115-119
22. Amini S., Mahmoodabadi A., Lamian S., Joulaie M., and Mahmoodi Farahani M. Prevalence of hepatitis G virus (HGV) in high-risk groups and blood donors in Tehran. Iran. Iranian J Public Health 34 (2005) 41-46
23. Zamani S., Ichikawa S., Nassirimanesh B., Vazirian M., Ichikawa K., Gouya M.M., et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy 18 (2007) 359-363
24. Zamani S., Kihara M., Gouya M.M., Vazirian M., Ono-Kihara M., Razzaghi E.M., et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS 19 (2005) 709-716
25. Center for Disease Management, Ministry of Health. Current statistics on HIV/AIDS infection in the Islamic Republic of Iran [in Persian]. Tehran: Iranian Ministry of Health; 2007, p. 6.
26. Vassilev Z.P., Hagan H., Lyubenova A., Tomov N., Vasilev G., Krasteva D., et al. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users. Int J STD AIDS 17 (2006) 621-626
27. Karimi A. Seroprevalence of HBV, HCV and HIV among intravenous drug users in Iran. J Clin Virol 36 Suppl 2 (2006) 210-211
28. Razzaghi E.M., and Rahimi-Movaghar A. Rapid assessment and response to injection drug use in Tehran (2005), World Health Organization and Iranian Welfare Organization, Tehran
29. Yao Y., Wang N., Chu J., Ding G., Jin X., Sun Y., et al. Sexual behavior and risks for HIV infection and transmission among male injecting drug users in Yunnan, China. Int J Infect Dis 13 (2009) 154-161
30. Abdala N., Krasnoselskikh T.V., Durante A.J., Timofeeva M.Y., Verevochkin S.V., and Kozlov A.P. Sexually transmitted infections, sexual risk behaviors and the risk of heterosexual spread of HIV among and beyond IDUs in St. Petersburg, Russia. Eur Addict Res 14 (2008) 19-25
31. Zocratto K.B., Caiaffa W.T., Proietti F.A., Carneiro-Proietti A.B., Mingoti S.A., and Ribeiro G.J. HCV and HIV infection and co-infection: injecting drug use and sexual behaviour. AjUDE-Brasil I Project. Cad Saude Publica 22 (2006) 839-848
32. Go V.F., Frangakis C., Nam le V., Bergenstrom A., Sripaipan T., Zenilman J.M., et al. High HIV sexual risk behaviors and sexually transmitted disease prevalence among injection drug users in Northern Vietnam: implications for a generalized HIV epidemic. J Acquir Immune Defic Syndr 42 (2006) 108-115
33. Altaf A., Shah S.A., Zaidi N.A., Memon A., Nadeem ur R., and Wray N. High risk behaviors of injection drug users registered with harm reduction programme in Karachi, Pakistan. Harm Reduct J 4 (2007) 7
34. Panda S., Saha U., Pahari S., Nathan M., Poddar S., Neogi D., et al. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection. Natl Med J India 15 (2002) 128-134
35. Azim T., Bogaerts J., Yirrell D.L., Banerjea A.C., Sarker M.S., Ahmed G., et al. Injecting drug users in Bangladesh: prevalence of syphilis, hepatitis. HIV and HIV subtypes. AIDS 16 (2002) 121-123
36. Hoffmann C.J., and Thio C.L. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 7 (2007) 402-409
37. Xia X., Luo J., Bai J., and Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health 122 (2008) 990-1003
38. Razzaghi E.M., Rahimi-Movaghar A., Hosseini M., Madani S., and Chatterjee A. Rapid situation assessment of drug abuse in Iran (1999), Iranian Welfare Organization and UNDCP, Tehran
39. Ghanbarzadeh N., and Nadjafi Semnani M. A study of HIV and other sexually transmitted infections among female prisoners in Birjand [in Persian]. J Birjand Univ Med Sci 13 (2006) 69-75
40. Jahani M.R., Alavian M., Shirzad H., Kabir A., and Hajarizadeh B. Distribution and risk factors of hepatitis B, hepatitis C, and HIV infection in a female population with illegal social behaviour. Sex Transm Infect 81 (2005) 181-185
41. Thorpe L.E., Ouellet L.J., Hershow R., Bailey S.L., Williams I.T., Williamson J., et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 155 (2002) 645-653